Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes…
Singapore, July 24, 2019: SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted…
San Francisco, July 04,2019: DayTwo, the microbiome human discovery platform that offers a glycemic control solution for people with type…
TOUJEOTMis a once daily, long-acting basal insulin used to control blood sugar in adults with type 1 and type 2…